Chronos Archive seal
The Human Record

Franklin D. Roosevelt

Case HR-ET002 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
January 30, 1882 – April 12, 1945
Synthetic DOB
1964-01-30
Index visit
2026-03-27 at age 62
Synthetic MRN
HR-ET002-SYN

Teaching objective: Diagnose and treat hypertensive heart failure with reduced ejection fraction using guideline-directed medical therapy, laboratory safety monitoring on the CMID schedule, iron repletion, and tobacco cessation, in a patient who uses a wheelchair, while keeping the contested cause of his 1921 paralysis out of the active diagnosis.

Historical timeline

DateEventClaims
January 30, 1882Born at Springwood in Hyde Park, New York.CLM-0001
1900Father died during his first term at Harvard.CLM-0009
August 25, 1921Paralytic illness diagnosed as infantile paralysis; paraplegic thereafter.CLM-0003, CLM-0004
May 1941Severe iron deficiency anemia.CLM-0005
September 1941Mother died at Springwood.CLM-0009
March 27, 1944Examined at Bethesda Naval Hospital: hypertension, enlarged heart, and congestive heart failure.CLM-0006, CLM-0007
February 1945Blood pressure reported up to 260/150.CLM-0008
April 12, 1945Died of a cerebral hemorrhage at Warm Springs, Georgia.CLM-0002, CLM-0008

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Franklin Delano Roosevelt was born on January 30, 1882, at Springwood, the family's estate in Hyde Park, New York. confirmed Springwood: Birthplace and Home to Franklin D. Roosevelt (Teaching with Historic Places) supports
D Roosevelt died of a cerebral hemorrhage at Warm Springs, Georgia, on April 12, 1945, aged 63.
Record the death as a fact without graphic detail.
confirmed Springwood: Birthplace and Home to Franklin D. Roosevelt (Teaching with Historic Places) supports
The Dying President supports
D In the summer of 1921 Roosevelt developed a paralytic illness at Campobello; on August 25, 1921, Dr. Robert Lovett diagnosed infantile paralysis (polio), and Roosevelt remained paraplegic, using leg braces from early 1922.
The contemporaneous diagnosis was polio; a later retrospective analysis proposes another cause.
confirmed FDR and Polio supports
Springwood: Birthplace and Home to Franklin D. Roosevelt (Teaching with Historic Places) supports
R A 2003 Bayesian analysis of the recorded symptoms concluded that Guillain-Barré syndrome was more probable than paralytic polio as the cause of Roosevelt's 1921 illness; the conclusion is disputed and cannot be confirmed because no cerebrospinal fluid was examined.
Keep the cause contested; the modern problem list records sequelae of the documented 1921 diagnosis.
disputed Goldman AS, Schmalstieg EJ, Freeman DH Jr, Goldman DA, Schmalstieg FC Jr. What was the cause of Franklin Delano Roosevelt's paralytic illness? J Med Biogr. 2003;11(4):232-240 supports
D In May 1941 Roosevelt had severe iron deficiency anemia, with hemoglobin reported at 4.5 g/100 mL.
Reported in a secondary medical account; the primary record was not reviewed.
probable Susmano A. Franklin Delano Roosevelt's last illness. Hektoen International. Spring 2012 supports
D At an examination at Bethesda Naval Hospital on March 27, 1944, Roosevelt's blood pressure was 186/108; he was breathless and cyanotic with rales, and X-rays and an electrocardiogram showed an enlarged heart, congestive heart failure, and a mitral murmur. His blood pressure had not been checked since February 27, 1941.
The documented anchor for the synthetic hypertensive heart failure episode.
confirmed The Dying President supports
Susmano A. Franklin Delano Roosevelt's last illness. Hektoen International. Spring 2012 supports
FDR: Secret Illness collection guide (citing Bruenn HG. Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Intern Med. 1970;72(4):579-591) context
D After the March 1944 examination Roosevelt was treated with digitalis, a low-sodium and weight-reduction diet, and rest; his working hours were reduced, his cigarettes were limited to ten a day, and his evening cocktails were reduced.
Documents tobacco use and the era's limited treatment options; no antihypertensive drugs were available.
confirmed The Dying President supports
Susmano A. Franklin Delano Roosevelt's last illness. Hektoen International. Spring 2012 supports
D Roosevelt's blood pressure remained severely elevated, reported up to 260/150 in February 1945 and ranging from 170/88 to 240/130 at Warm Springs before his death. confirmed Susmano A. Franklin Delano Roosevelt's last illness. Hektoen International. Spring 2012 supports
The Dying President supports
D Roosevelt's father, James Roosevelt, died in 1900 during Franklin's first term at Harvard; his mother, Sara Delano Roosevelt, died at Springwood in September 1941.
The cited source does not give causes of death.
confirmed Springwood: Birthplace and Home to Franklin D. Roosevelt (Teaching with Historic Places) supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Hypertensive heart disease with heart failure; synthetic modern diagnosis linked to the documented 1944 findings active confirmed both_with_link CLM-0006, CLM-0008
S Heart failure with reduced ejection fraction, NYHA class III at diagnosis active confirmed both_with_link CLM-0006
S Nicotine dependence, cigarettes active confirmed active CLM-0007
S Iron deficiency anemia in heart failure, repleted with intravenous iron resolved confirmed active CLM-0005
S Paraplegia from a paralytic illness at age 39, historically diagnosed as poliomyelitis; cause retrospectively disputed active provisional both_with_link CLM-0003, CLM-0004
S Prediabetes active confirmed active
S Hyperlipidemia active confirmed active
S Acute viral gastroenteritis with mild volume depletion, resolved with oral rehydration and a short hold of heart failure medicines resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-03-27 Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 2850 pg/mL (high)
Reference <=125 pg/mL
http://loinc.org · 33762-6
S 2026-03-27 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-03-27 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-03-27 Creatinine [Mass/volume] in Serum or Plasma 1.18 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-03-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 70 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-03-27 Glucose [Mass/volume] in Serum or Plasma 104 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-03-27 Hemoglobin [Mass/volume] in Blood 12.6 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-03-27 Ferritin [Mass/volume] in Serum or Plasma 48 ng/mL
Reference 30-400 ng/mL
http://loinc.org · 2276-4
S 2026-03-27 Iron saturation [Mass Fraction] in Serum or Plasma 16% (low)
Reference 20-50%
http://loinc.org · 2502-3
S 2026-03-27 Thyrotropin [Units/volume] in Serum or Plasma 2.1 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-03-27 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 132 mg/dL (high)
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 2026-03-27 Hemoglobin A1c/Hemoglobin.total in Blood 5.9% (high)
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-03-27 Albumin/Creatinine [Mass Ratio] in Urine 64 mg/g (high)
Reference <=30 mg/g
http://loinc.org · 9318-7
S 2026-03-27 Overall summary score [KCCQ-12] 38 http://loinc.org · 86924-8
S 2026-03-27 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-04-10 Sodium [Moles/volume] in Serum or Plasma 136 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-04-10 Potassium [Moles/volume] in Serum or Plasma 4.8 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-04-10 Creatinine [Mass/volume] in Serum or Plasma 1.29 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-04-10 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 63 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-04-10 Glucose [Mass/volume] in Serum or Plasma 98 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-04-10 Left ventricular Ejection fraction 30% (low)
Reference 50-70%
http://loinc.org · 10230-1
S 2026-06-26 Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 980 pg/mL (high)
Reference <=125 pg/mL
http://loinc.org · 33762-6
S 2026-06-26 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-06-26 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-06-26 Creatinine [Mass/volume] in Serum or Plasma 1.24 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-06-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 66 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-06-26 Glucose [Mass/volume] in Serum or Plasma 96 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-06-26 Hemoglobin [Mass/volume] in Blood 13.6 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-06-26 Ferritin [Mass/volume] in Serum or Plasma 236 ng/mL
Reference 30-400 ng/mL
http://loinc.org · 2276-4
S 2026-06-26 Iron saturation [Mass Fraction] in Serum or Plasma 27%
Reference 20-50%
http://loinc.org · 2502-3
S 2026-06-26 Overall summary score [KCCQ-12] 64 http://loinc.org · 86924-8
S 2026-06-26 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-09-25 Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 410 pg/mL (high)
Reference <=125 pg/mL
http://loinc.org · 33762-6
S 2026-09-25 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-09-25 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-09-25 Creatinine [Mass/volume] in Serum or Plasma 1.21 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-09-25 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 68 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-09-25 Glucose [Mass/volume] in Serum or Plasma 95 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-09-25 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 68 mg/dL
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 2026-09-25 Albumin/Creatinine [Mass Ratio] in Urine 22 mg/g
Reference <=30 mg/g
http://loinc.org · 9318-7
S 2026-09-25 Left ventricular Ejection fraction 45% (low)
Reference 50-70%
http://loinc.org · 10230-1
S 2026-09-25 Overall summary score [KCCQ-12] 78 http://loinc.org · 86924-8
S 2026-07-27 Sodium [Moles/volume] in Serum or Plasma 135 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-07-27 Potassium [Moles/volume] in Serum or Plasma 4.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-07-27 Creatinine [Mass/volume] in Serum or Plasma 1.42 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-07-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 56 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-07-27 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-10-23 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-23 Total score [AUDIT-C] 2 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-03-27Body height188 cm8302-2S
2026-03-27Body weight88 kg29463-7S
2026-03-27Body mass index (BMI) [Ratio]24.9 kg/m239156-5S
2026-03-27Systolic blood pressure186 mm[Hg]8480-6S
2026-03-27Diastolic blood pressure108 mm[Hg]8462-4S
2026-03-27Heart rate96 /min8867-4S
2026-03-27Respiratory rate22 /min9279-1S
2026-03-27Body temperature36.9 Cel8310-5S
2026-03-27Oxygen saturation in Arterial blood by Pulse oximetry93 %59408-5S
2026-04-10Body height188 cm8302-2S
2026-04-10Body weight85 kg29463-7S
2026-04-10Body mass index (BMI) [Ratio]24 kg/m239156-5S
2026-04-10Systolic blood pressure148 mm[Hg]8480-6S
2026-04-10Diastolic blood pressure88 mm[Hg]8462-4S
2026-04-10Heart rate84 /min8867-4S
2026-04-10Respiratory rate18 /min9279-1S
2026-04-10Body temperature36.8 Cel8310-5S
2026-04-10Oxygen saturation in Arterial blood by Pulse oximetry95 %59408-5S
2026-06-26Body height188 cm8302-2S
2026-06-26Body weight83 kg29463-7S
2026-06-26Body mass index (BMI) [Ratio]23.5 kg/m239156-5S
2026-06-26Systolic blood pressure128 mm[Hg]8480-6S
2026-06-26Diastolic blood pressure78 mm[Hg]8462-4S
2026-06-26Heart rate70 /min8867-4S
2026-06-26Respiratory rate16 /min9279-1S
2026-06-26Body temperature36.7 Cel8310-5S
2026-06-26Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-09-25Body height188 cm8302-2S
2026-09-25Body weight82 kg29463-7S
2026-09-25Body mass index (BMI) [Ratio]23.2 kg/m239156-5S
2026-09-25Systolic blood pressure122 mm[Hg]8480-6S
2026-09-25Diastolic blood pressure76 mm[Hg]8462-4S
2026-09-25Heart rate64 /min8867-4S
2026-09-25Respiratory rate14 /min9279-1S
2026-09-25Body temperature36.7 Cel8310-5S
2026-09-25Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-27Body height188 cm8302-2S
2026-07-27Body weight80.6 kg29463-7S
2026-07-27Body mass index (BMI) [Ratio]22.8 kg/m239156-5S
2026-07-27Systolic blood pressure102 mm[Hg]8480-6S
2026-07-27Diastolic blood pressure64 mm[Hg]8462-4S
2026-07-27Heart rate86 /min8867-4S
2026-07-27Respiratory rate16 /min9279-1S
2026-07-27Body temperature37.6 Cel8310-5S
2026-07-27Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-10-23Body height188 cm8302-2S
2026-10-23Body weight82 kg29463-7S
2026-10-23Body mass index (BMI) [Ratio]23.2 kg/m239156-5S
2026-10-23Systolic blood pressure120 mm[Hg]8480-6S
2026-10-23Diastolic blood pressure74 mm[Hg]8462-4S
2026-10-23Heart rate62 /min8867-4S
2026-10-23Respiratory rate14 /min9279-1S
2026-10-23Body temperature36.6 Cel8310-5S
2026-10-23Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Lower blood pressure below 130/80 by the six-month review2026-09-25completedBlood pressure 122/76
Improve the KCCQ-12 overall summary score by at least 20 points by the three-month review2026-06-26completedKCCQ-12 rose from 38 to 64
Stop smoking by the three-month review2026-06-26completedNo cigarettes since April; nicotine patch course completed
Reach the highest tolerated doses of guideline-directed therapy by the six-month review2026-09-25completedSacubitril/valsartan 49/51 mg twice daily, carvedilol 12.5 mg twice daily, spironolactone, and empagliflozin

Interventions

InterventionStatusGuideline
Start guideline-directed therapy for HFrEF: sacubitril/valsartan, carvedilol, and empagliflozin, with furosemide for congestion; add spironolactone after the two-week potassium checkcompletedGL-HF-2022
Check a basic metabolic panel one to two weeks after each renin-angiotensin or mineralocorticoid antagonist change, then every three to six months when stablecompletedGL-CMID-2026, GL-HF-2022
Treat to a blood pressure below 130/80 with home blood pressure and daily weight logs; low-sodium dietcompletedGL-HTN-2025, GL-CMID-2026
Give intravenous ferric carboxymaltose for iron deficiency with ferritin below 100 ng/mL and transferrin saturation below 20%completedGL-HF-2022
Tobacco cessation counseling with nicotine replacement and a quit datecompletedGL-TOBACCO-2021
Cardiology referral to confirm the diagnosis, review the echocardiogram, and guide titrationcompletedGL-HF-2022
Repeat echocardiogram three to six months after reaching tolerated doses to decide on device therapycompletedGL-HF-2022, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Springwood: Birthplace and Home to Franklin D. Roosevelt (Teaching with Historic Places) U.S. National Park Service government
SRC-0002 FDR and Polio Franklin D. Roosevelt Presidential Library and Museum government
SRC-0003 The Dying President U.S. National Park Service, Home of Franklin D. Roosevelt National Historic Site government
SRC-0004 Susmano A. Franklin Delano Roosevelt's last illness. Hektoen International. Spring 2012 Hektoen International scholarly
SRC-0005 Goldman AS, Schmalstieg EJ, Freeman DH Jr, Goldman DA, Schmalstieg FC Jr. What was the cause of Franklin Delano Roosevelt's paralytic illness? J Med Biogr. 2003;11(4):232-240 Journal of Medical Biography (PubMed 14562158) scholarly
SRC-0006 HISTMED Master Roster v3 The Human Record project other
SRC-0007 FDR: Secret Illness collection guide (citing Bruenn HG. Clinical notes on the illness and death of President Franklin D. Roosevelt. Ann Intern Med. 1970;72(4):579-591) University of Arizona Health Sciences Library other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review.
provenance reviewnot_startedNPS, FDR Library, and PubMed abstract logged; Bruenn's 1970 article not reviewed in full.
safe messaging reviewnot_startedNo behavioral-health content; death recorded without graphic detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.